Possible Role of Mitochondrial Transfer RNA Gene 5816 A > G Genetic Polymorphism (m.5816A > G) in a 3-Year-Old Child with Dystonia: Report of a Case

Abstract

Background Mutations in the mitochondrial transfer RNA (mt-tRNA) gene are a hotspot for mitochondrial DNA (mtDNA) mutations and are most common in mitochondrial diseases.

Methods We identified the mt-tRNA gene 5816 A > G (m.5816 A > G) mutation in a 3-year-old child with dystonia who died. We performed clinical evaluation, genetic analysis, and biochemical investigation with mitochondrial function testing.

Results Our patient was found to have dystonia with hyperlactatemia. Electroencephalogram findings were abnormal in children with numerous multifocal spikes, multispike, spikes and slow waves, slow waves and low amplitude fast waves, more pronounced in the occipital region bilaterally, and occurring continuously during sleep. One year later, the preexisting patient had seizures lasting 1 to 2 hours and subsequently died. mtDNA sequencing revealed that the proband, her mother, and her grandmother all carried the m.5816A > G mutation. Oxygen consumption rate (OCR) assays revealed that the proband's basal resting OCR, adenosine triphosphate production, proton leak, maximal respiration, and spare capacity OCR were all significantly lower compared with healthy children of the same age.

Conclusion The present case demonstrates a childhood dystonia caused by a mt-tRNA gene 5816 A > G mutation, which has never been reported before. Our findings provide valuable new insights into the pathogenic mechanism and function of the m.5816A > G mutation.

Keywords

mitochondrial DNA mutation - mitochondrial diseases - dystonia - epilepsy

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this case report.

Authors' Contribution

D.S. and F.Z. designed the study; S.W. and M.L. collected the data and clinical information; J.M., S.H., and L.F. performed the bioinformatics analysis; S.W. wrote the original manuscript; D.S. revised the manuscript. All authors have read and agreed to the published version of the manuscript.

^* These authors contributed equally to this work.

Publication History

Article published online:
27 September 2023

• References

• 1 Albanese A, Bhatia K, Bressman SB. et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013; 28 (07) 863-873
• 2 di Biase L, Di Santo A, Caminiti ML, Pecoraro PM, Carbone SP, Di Lazzaro V. Dystonia diagnosis: clinical neurophysiology and genetics. J Clin Med 2022; 11 (14) 4184
• 3 Svetel M, Kozić D, Stefanova E, Semnic R, Dragasevic N, Kostic VS. Dystonia in Wilson's disease. Mov Disord 2001; 16 (04) 719-723
• 4 Ross CA. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 2002; 35 (05) 819-822
• 5 Mattman A, Sirrs S, Mezei MM, Salvarinova-Zivkovic R, Alfadhel M, Lillquist Y. Mitochondrial disease clinical manifestations: an overview. B C Med J 2011; 53 (04) 183-187
• 6 Ng YS, Turnbull DM. Mitochondrial disease: genetics and management. J Neurol 2016; 263 (01) 179-191
• 7 MitoCanada. Mitochondrial disease [Internet]. MitoCanada; 2022. [cited January 27, 2022]. Available at: https://mitocanada.org/mitochondrial-disease/
• 8 Rosales XQ, Thompson JLP, Haas R. et al; North American Mitochondrial Disease Consortium. The North American mitochondrial disease registry. J Transl Genet Genom 2020; 4 (02) 81-90
• 9 Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 2018; 34 (17) i884-i890
• 10 Li H, Handsaker B, Wysoker A. et al; 1000 Genome Project Data Processing Subgroup. The sequence alignment/map format and SAMtools. Bioinformatics 2009; 25 (16) 2078-2079
• 11 Bandelt HJ, Kloss-Brandstätter A, Richards MB, Yao YG, Logan I. The case for the continuing use of the revised Cambridge Reference Sequence (rCRS) and the standardization of notation in human mitochondrial DNA studies. J Hum Genet 2014; 59 (02) 66-77
• 12 Lai Z, Markovets A, Ahdesmaki M. et al. VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids Res 2016; 44 (11) e108
• 13 Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38 (16) e164
• 14 Falk MJ, Shen L, Gonzalez M. et al; MSeqDR Consortium Participants, MSeqDR Consortium participants: Sherri Bale, Jirair Bedoyan, Doron Behar, Penelope Bonnen, Lisa Brooks, Claudia Calabrese, Sarah Calvo, Patrick Chinnery, John Christodoulou, Deanna Church, Rosanna Clima, Bruce H. Cohen, Richard G. Cotton, IFM de Coo, Olga Derbenevoa, Johan T. den Dunnen, David Dimmock, Gregory Enns, Giuseppe Gasparre, Amy Goldstein, Iris Gonzalez, Katrina Gwinn, Sihoun Hahn, Richard H. Haas, Hakon Hakonarson, Michio Hirano, Douglas Kerr, Dong Li, Maria Lvova, Finley Macrae, Donna Maglott, Elizabeth McCormick, Grant Mitchell, Vamsi K. Mootha, Yasushi Okazaki, Aurora Pujol, Melissa Parisi, Juan Carlos Perin, Eric A. Pierce, Vincent Procaccio, Shamima Rahman, Honey Reddi, Heidi Rehm, Erin Riggs, Richard Rodenburg, Yaffa Rubinstein, Russell Saneto, Mariangela Santorsola, Curt Scharfe, Claire Sheldon, Eric A. Shoubridge, Domenico Simone, Bert Smeets, Jan A. Smeitink, Christine Stanley, Anu Suomalainen, Mark Tarnopolsky, Isabelle Thiffault, David R. Thorburn, Johan Van Hove, Lynne Wolfe, and Lee-Jun Wong. Mitochondrial Disease Sequence Data Resource (MSeqDR): a global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities. Mol Genet Metab 2015; 114 (03) 388-396
• 15 Gandhi S, Abramov AY. Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev 2012; 2012: 428010
• 16 Annesley SJ, Fisher PR. Mitochondria in health and disease. Cells 2019; 8 (07) 680
• 17 Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial diseases: hope for the future. Cell 2020; 181 (01) 168-188
• 18 Gorman GS, Chinnery PF, DiMauro S. et al. Mitochondrial diseases. Nat Rev Dis Primers 2016; 2: 16080
• 19 Li H, Liu D, Lu J, Bai Y. Physiology and pathophysiology of mitochondrial DNA. Adv Exp Med Biol 2012; 942: 39-51
• 20 Bohnsack MT, Sloan KE. The mitochondrial epitranscriptome: the roles of RNA modifications in mitochondrial translation and human disease. Cell Mol Life Sci 2018; 75 (02) 241-260
• 21 Ng YS, Bindoff LA, Gorman GS. et al. Mitochondrial disease in adults: recent advances and future promise. Lancet Neurol 2021; 20 (07) 573-584
• 22 Ruiz-Pesini E, Lott MT, Procaccio V. et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 2007; 35 (Database issue): D823-D828
• 23 Lin Y, Xu X, Wang W. et al. A mitochondrial myopathy-associated tRNA^Ser(UCN) 7453G>A mutation alters tRNA metabolism and mitochondrial function. Mitochondrion 2021; 57: 1-8
• 24 Yarham JW, Elson JL, Blakely EL, McFarland R, Taylor RW. Mitochondrial tRNA mutations and disease. Wiley Interdiscip Rev RNA 2010; 1 (02) 304-324
• 25 Scuderi C, Borgione E, Musumeci S. et al. Severe encephalomyopathy in a patient with homoplasmic A5814G point mutation in mitochondrial tRNACys gene. Neuromuscul Disord 2007; 17 (03) 258-261
• 26 Brandon MC, Lott MT, Nguyen KC. et al. MITOMAP: a human mitochondrial genome database–2004 update. Nucleic Acids Res 2005; 33 (Database issue): D611-D613
• 27 Carter Jr CW, Wolfenden R. tRNA acceptor-stem and anticodon bases embed separate features of amino acid chemistry. RNA Biol 2016; 13 (02) 145-151
• 28 McFarland R, Chinnery PF, Blakely EL. et al. Homoplasmy, heteroplasmy, and mitochondrial dystonia. Neurology 2007; 69 (09) 911-916